Precigen (PGEN) Interest Coverage Ratio (QoQ) (2012 - 2026)
Precigen (PGEN) Interest Coverage Ratio (QoQ) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Precigen |
1.32 Bn |
1.32 Bn |
20.69 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
71.80% |
| Dec 31, 2025 |
80.88% |
| Sep 30, 2024 |
65.05% |
| Jun 30, 2024 |
-149.25% |
| Mar 31, 2024 |
-149.63% |
| Dec 31, 2023 |
76.65% |
| Sep 30, 2023 |
-13,382.16% |
| Jun 30, 2023 |
-114.31% |
| Mar 31, 2023 |
-111.77% |
| Dec 31, 2022 |
-815.00% |
| Sep 30, 2022 |
68.07% |
| Jun 30, 2022 |
-7.75% |
| Mar 31, 2022 |
-141.18% |
| Dec 31, 2021 |
0.25% |
| Sep 30, 2021 |
20.15% |
| Jun 30, 2021 |
-45.21% |
| Mar 31, 2021 |
-94.95% |
| Dec 31, 2020 |
98.72% |
| Sep 30, 2020 |
-209.57% |
| Jun 30, 2020 |
-1,298.50% |
